Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

HD-PTP inhibits endothelial migration through its interaction with Src.

Mariotti M, Castiglioni S, Garcia-Manteiga JM, Beguinot L, Maier JA.

Int J Biochem Cell Biol. 2009 Mar;41(3):687-93. doi: 10.1016/j.biocel.2008.08.005. Epub 2008 Aug 9.

PMID:
18762272
2.

The tyrosine phosphatase HD-PTP is regulated by FGF-2 through proteasome degradation.

Mariotti M, Castiglioni S, Beguinot L, Maier JA.

Front Biosci. 2006 Sep 1;11:2138-43.

3.

Effect of tyrosine kinase inhibitors on clathrin-coated pit recruitment and internalization of epidermal growth factor receptor.

Sorkina T, Huang F, Beguinot L, Sorkin A.

J Biol Chem. 2002 Jul 26;277(30):27433-41. Epub 2002 May 20.

4.

Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines.

Moro L, Dolce L, Cabodi S, Bergatto E, Boeri Erba E, Smeriglio M, Turco E, Retta SF, Giuffrida MG, Venturino M, Godovac-Zimmermann J, Conti A, Schaefer E, Beguinot L, Tacchetti C, Gaggini P, Silengo L, Tarone G, Defilippi P.

J Biol Chem. 2002 Mar 15;277(11):9405-14. Epub 2001 Dec 27.

5.

Conformational analysis of the phosphorylated epidermal growth factor receptor.

Bishayee A, Beguinot L, Bishayee S.

Biosci Rep. 1999 Oct;19(5):397-402.

PMID:
10763807
7.

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.

Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y.

Genes Dev. 1998 Dec 1;12(23):3663-74.

8.

Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival.

Moro L, Venturino M, Bozzo C, Silengo L, Altruda F, Beguinot L, Tarone G, Defilippi P.

EMBO J. 1998 Nov 16;17(22):6622-32.

9.

PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.

Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F, Cafieri A, Tecce MF, Formisano P, Beguinot L, Beguinot F.

EMBO J. 1998 Jul 15;17(14):3858-66.

10.
11.

Post-transcriptional control regulates transforming growth factor alpha in the human carcinoma KB cell line.

Nicolini G, Miloso M, Moroni MC, Beguinot L, Scotto L.

J Biol Chem. 1996 Nov 22;271(47):30290-6.

12.

Epidermal growth factor receptor interaction with clathrin adaptors is mediated by the Tyr974-containing internalization motif.

Sorkin A, Mazzotti M, Sorkina T, Scotto L, Beguinot L.

J Biol Chem. 1996 Jun 7;271(23):13377-84.

13.

Interaction of signaling and trafficking proteins with the carboxyterminus of the epidermal growth factor receptor.

Carpenter G, Soler C, Baulida J, Beguinot L, Sorkin A.

Ann N Y Acad Sci. 1995 Sep 7;766:44-51. Review. No abstract available.

PMID:
7486689
14.
16.

Biochemical characterization of human GCF transcription factor in tumor cells.

Beguinot L, Yamazaki H, Pastan I, Johnson AC.

Cell Growth Differ. 1995 Jun;6(6):699-706.

17.
18.

Internalization of the constitutively active arginine 1152-->glutamine insulin receptor occurs independently of insulin at an accelerated rate.

Formisano P, DeNovellis G, Miele C, Tripodi F, Caruso M, Palumbo G, Beguinot L, Beguinot F.

J Biol Chem. 1994 Jun 10;269(23):16242-6.

20.
21.

Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln1152 insulin receptor mutation.

Petruzziello A, Formisano P, Miele C, Di Finizio B, Riccardi G, Ferrara A, Beguinot L, Beguinot F.

J Clin Endocrinol Metab. 1993 Aug;77(2):409-12.

PMID:
8393885
22.

Mutation in a conserved motif next to the insulin receptor key autophosphorylation sites de-regulates kinase activity and impairs insulin action.

Formisano P, Sohn KJ, Miele C, Di Finizio B, Petruzziello A, Riccardi G, Beguinot L, Beguinot F.

J Biol Chem. 1993 Mar 5;268(7):5241-8.

25.

Epidermal growth factor receptor in human brain tumors.

Di Carlo A, Mariano A, Macchia PE, Moroni MC, Beguinot L, Macchia V.

J Endocrinol Invest. 1992 Jan;15(1):31-7.

PMID:
1560188
26.

Transmembrane signalling at the epidermal growth factor receptor. Positive regulation by the C-terminal phosphotyrosine residues.

Magni M, Pandiella A, Helin K, Meldolesi J, Beguinot L.

Biochem J. 1991 Jul 15;277 ( Pt 2):305-11.

28.

The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines.

Helin K, Velu T, Martin P, Vass WC, Allevato G, Lowy DR, Beguinot L.

Oncogene. 1991 May;6(5):825-32.

PMID:
1646987
29.

Epidermal growth factor receptor and thyrotropin response in human thyroid tissues.

Di Carlo A, Mariano A, Pisano G, Parmeggiani U, Beguinot L, Macchia V.

J Endocrinol Invest. 1990 Apr;13(4):293-9.

PMID:
2164546
30.

Transmembrane signalling at the epidermal growth factor receptor.

Pandiella A, Beguinot L, Vicentini LM, Meldolesi J.

Trends Pharmacol Sci. 1989 Oct;10(10):411-4. Review.

PMID:
2694537
32.

Retroviruses expressing different levels of the normal epidermal growth factor receptor: biological properties and new bioassay.

Velu TJ, Beguinot L, Vass WC, Zhang K, Pastan I, Lowy DR.

J Cell Biochem. 1989 Feb;39(2):153-66.

PMID:
2565908
33.

Receptor downregulation and DNA synthesis are modulated by EGF and TPA in cells expressing an EGFR/neu chimera.

Lehtola L, Lehväslaiho H, Sistonen L, Beguinot L, Alitalo K.

Growth Factors. 1989;1(4):323-34.

PMID:
2699432
35.

Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.

Velu TJ, Beguinot L, Vass WC, Willingham MC, Merlino GT, Pastan I, Lowy DR.

Science. 1987 Dec 4;238(4832):1408-10.

PMID:
3500513
36.

Thyrotropin regulation of membrane lipid fluidity in the FRTL-5 thyroid cell line. Its relationship to cell growth and functional activity.

Beguinot F, Beguinot L, Tramontano D, Duilio C, Formisano S, Bifulco M, Ambesi-Impiombato FS, Aloj SM.

J Biol Chem. 1987 Feb 5;262(4):1575-82.

37.

Alteration in the transmission of TSH-message to thyroid target in a transplantable rat thyroid tumor.

Laccetti P, Meldolesi MF, Beguinot L, Mariano A, Macchia V.

J Endocrinol Invest. 1986 Oct;9(5):359-66.

PMID:
3794181
38.

Synthesis of epidermal growth factor (EGF) receptor in vitro using SP6 RNA polymerase-transcribed template mRNA.

Clark AJ, Beguinot L, Ishii S, Ma DP, Roe BA, Merlino GT, Pastan I.

Biochim Biophys Acta. 1986 Aug 22;867(4):244-51.

PMID:
3017432
39.

Functional studies on the EGF receptor with an antibody that recognizes the intracellular portion of the receptor.

Beguinot L, Werth D, Ito S, Richert N, Willingham MC, Pastan I.

J Biol Chem. 1986 Feb 5;261(4):1801-7.

40.

In vitro activation of adenylate cyclase of atrophic celiac intestinal mucosa by wheat gliadin-derived peptides.

Beguinot L, Auricchio S, Bernardin JE, de Ritis G, De Vincenzi M, Kasarda DD, Macchia V, Silano V.

Pediatr Res. 1986 Jan;20(1):42-4.

PMID:
3945514
41.
42.

Alteration of erythrocyte membrane lipid fluidity in human obesity.

Beguinot F, Tramontano D, Duilio C, Formisano S, Beguinot L, Mattioli P, Mancini M, Aloj SM.

J Clin Endocrinol Metab. 1985 Jun;60(6):1226-30.

PMID:
3998068
43.

Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.

Beguinot L, Hanover JA, Ito S, Richert ND, Willingham MC, Pastan I.

Proc Natl Acad Sci U S A. 1985 May;82(9):2774-8.

44.
45.

Isolation and characterization of a highly enriched preparation of receptosomes (endosomes) from a human cell line.

Dickson RB, Beguinot L, Hanover JA, Richert ND, Willingham MC, Pastan I.

Proc Natl Acad Sci U S A. 1983 Sep;80(17):5335-9.

46.

Development of guanylate cyclase activity in mouse embryonic lung.

Macchia V, Beguinot L, Garbi C, Alescio T.

Acta Embryol Exp (Palermo). 1978;(2):213-27. No abstract available.

PMID:
34309

Supplemental Content

Loading ...
Support Center